The United States CPAP market is projected to reach USD 4,229.1 million in the year 2025 and is expected to total USD 6,320.5 million by the end of 2035, growing at a compound annual growth rate (CAGR) of 4.1% over the forecast years from 2025 to 2035.
| Attributes | Values |
|---|---|
| Estimated Industry Size 2025 | USD 4,229.1 million |
| Projected Value 2035 | USD 6,320.5 million |
| Value-based CAGR from 2025 to 2035 | 4.1% |
This aspect is highly increased in the United States, given the diagnosis of sleep apnea and other respiratory conditions. This comes mainly about the growing rates of obesity, which is one of the highest risk factors for obstructive sleep apnea. The more it rises, the more will be the demand of CPAP usage.
The risks associated with undiagnosed sleep apnea, such as causes of diabetes, heart diseases, and hypertension, have led to continuous public awareness campaigns urging people to seek early diagnosis and treatment. In the CPAP market, one area that has really affected this market is the technological advancement.
Most manufacturers are making devices portable and lightweight, hence friendly to the user. Nowadays, the smart technology CPAP machines can auto-adjust air pressure, and some come with built-in humidifiers. These machines offer real-time monitoring.
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
The table below offers a detailed comparative assessment of the changes in the compound annual growth rate (CAGR) over six months for the base year (2023) and the current year (2024) specifically for the United States continuous positive airway pressure (CPAP) market.
This semiannual analysis highlights all the critical shifts of market dynamics as well as details the revenue realization pattern, thus more precisely providing to the stakeholders insight into the trajectory of growth within a year. In other words, H1 contains January to June, and the other half H2 contains July to December.
-market-actual-vs-estimated-cagr.png "United States Continuous Positive Airway Pressure (cpap) Market Actual Vs Estimated Cagr")
H1 signifies period from January to June, H2 Signifies period from July to December
The continuous positive airway pressure (CPAP) sector for the United States market is expected to grow at a CAGR of 2.9% in the first half of 2023, which will increase to 3.5% in the second half of the same year. In 2024, the growth rate is expected to slightly decline to 3.1% in H1 but is expected to rise to 3.5% in H2.
This pattern shows a decline of 20 basis points from the first half of 2023 to the first half of 2024, while in the second half of 2024, it is higher by 4 basis points compared to the second half of 2023.
These figures represent a dynamic and fast-changing United States continuous positive airway pressure (CPAP) market, largely influenced by regulations, consumer trends, and improvements in continuous positive airway pressure (CPAP). This semestral breakup is crucial to businesses that chart their strategies, taking into consideration the growth trends and navigating market complexities.
| Date | Development/M&A Activity & Details |
|---|---|
| 2025 | Technology Development: ResMed is a mission in the development and support of technology that advances the human health and happiness through easier breathing and better sleep. The company envisions an ideal world where every breath contributes to health, and every sleep is restorative. |
| 2024 | Product Launch: New bi-level sleep apnea device that serves as an alternative CPAP was launched by ResMed last February 2024. |
| 2024 | Product Innovation: DeVilbiss Healthcare, drives innovation among the lines of products and puts quite a lot of resource development into research and development. Drives DeVilbiss Healthcare also believes in quality customer service and renders technical support and education to healthcare providers in order to ensure the best use of products and patient care. |
Increasing Incidence of Obstructive Sleep Apnea and Respiratory Disorders
The main growth driver for the USA CPAP market is the increasing cases of obstructive sleep apnea and other respiratory disorders. Such a higher incidence of sleep disorders is associated with the increasing obesity rates, aging population, and lifestyle changes.
Increasing awareness of sleep apnea among patients and healthcare providers has stirred critical attention and care among patients regarding the serious health implications of undiagnosed sleep apnea, which include diseases such as cardiovascular diseases and stroke. This has resulted in earlier diagnosis and treatment, encouraging CPAP adoption.
Technological advancements and usability features
Manufacturers have innovated the CPAP machine to make it smaller, portable, and patient-friendly. Today, the modern features include automatic changes in pressure, built-in humidifiers, and a mobile application to follow up with patients. This has significantly improved patient compliance and outcomes. These technological developments, along with increasing telemedicine integration, make CPAP therapy easier and more accessible, which propels the market further in the United States.
% share of Individual categories by Product Type and End User in 2025
-market-total-vs-top-product-selling.png "United States Continuous Positive Airway Pressure (cpap) Market Total Vs Top Product Selling")
PAP devices including CPAP, BiPAP, and APAP comprise the gold standard for treating sleep apnea and other such respiratory conditions. Their dominance is attributed to increased prevalence of sleeping disorders, enhanced obesity rates in the USA, and public awareness of perils of not treating sleep apnea.
For both patients as well as healthcare service providers, insurance covers and reimbursement are also more accommodative towards PAP therapy. Advances in technology are quieter motors, portability, and smart connectivity, which enhance patient compliance and adoption rates.
Hospitals also play a role in the adoption and utilization of PAP devices since they are primary centers for diagnosing and managing respiratory conditions. In fact, most patients first get their CPAP or BiPAP therapy prescriptions after sleep studies done in hospital-based sleep labs.
Hospitals also use PAP devices for acute respiratory care in the ICUs and emergency settings where non-invasive ventilation is important in managing patients with conditions such as COPD, pneumonia, and post-surgical recovery. Early diagnosis has a growing emphasis, along with the rising number of hospital admissions due to respiratory-related disorders in the USA, further supporting the need for PAP devices.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
The USA CPAP market is moderately consolidated with the presence of both global healthcare giants and specialized respiratory device manufacturers. It's for these reasons that competitors have had to fight for market share-they all possess robust brands, have continuously innovate in product lines, and offer extensive networks of distribution.
The global industry leaders are ResMed, Philips Respironics, and Fisher & Paykel Healthcare. They continue to provide high-end CPAP solutions for instance smart PAP systems that are linked up with cloud-based monitoring for enhanced patient compliance, auto-adjusting CPAPs, travel-friendly models.
Ever increasing technological progress and the strict regulations are still driving the USA CPAP competition, while an increase in patient awareness can lead to greater acceptance. Companies remain keen on investing heavily in research and development to improve comfort, noise levels, and AI-driven data analysis to personalize treatment.
Shifts towards care at home and telemedicine have increased further the need for CPAP devices with remote monitoring capabilities, which is encouraging manufacturers to present digital health solutions to patients. Regulatory frameworks also help define competition within the market. The FDA oversight on CPAP devices, recall, and matters of safety have pushed companies to focus more on product quality as well as innovation.
2025 Market share of United States Continuous Positive Airway Pressure (CPAP) suppliers
-market-revenue-share-by-compony-2025.png "United States Continuous Positive Airway Pressure (cpap) Market Revenue Share By Compony 2025")
Note: above chart is indicative in nature
In terms of product, the industry is divided into PAP Devices (CPAP, BIPAP, and Auto CPAP), Humidifier, Masks (Full Face Masks, Nasal Masks, and Nasal Pillow Masks) and Accessories.
In terms of patient type, the industry is segregated into infants, premature, adults.
In terms of indication, the industry is segregated into chronic respiratory failure, respiratory distress syndrome (RDS), sleep apnea disorders, hypoxemia and hypoxia, among other indications.
In terms of end user, the industry is divided into hospitals, home care settings, clinics, intensive care units and sleep disorder centers.
By 2025, the United States continuous positive airway pressure (CPAP) market is expected to grow at a CAGR of 4.1%.
By 2035, the sales value of the United States continuous positive airway pressure (CPAP) industry is expected to reach United States is 6,320.5 million.
Key factors propelling the United States continuous positive airway pressure (CPAP) market include rising prevalence of chronic respiratory diseases and rise in obesity rates.
Prominent players in the United States continuous positive airway pressure (CPAP) manufacturing include ResMed, Fisher & Paykel Healthcare, Draegerwerk AG & Co. KGaA, Medtronics, ReactHealth (3B Medical, Inc.), DeVilbiss Healthcare, Armstrong Medical, BMC Medical Co. Ltd, Hamilton Medical AG, Hebei Topson Medical Technology Co., Ltd., Nanjing Superstar Medical Equipment, SS TECHNOMED, Inspiration Healthcare(Viomedex Limited), Pigeon Medical and Others. These companies are noted for their innovation, extensive product portfolios, and strategic market positioning.
Explore Therapeutic Device Insights
View Reports
United States Continuous Positive Airway Pressure (CPAP) Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
